Your browser doesn't support javascript.
loading
Bi-weekly eribulin therapy for metastatic breast cancer: a multicenter phase II prospective study (JUST-STUDY).
Ohtani, Shoichiro; Nakayama, Takahiro; Yoshinami, Tetsuhiro; Watanabe, Ken-Ichi; Hara, Fumikata; Sagara, Yasuaki; Kawaguchi, Hidetoshi; Higaki, Kenji; Matsunami, Nobuki; Hasegawa, Yoshie; Takahashi, Masato; Mizutani, Makiko; Morimoto, Takashi; Sato, Masako; Itoh, Mitsuya; Morita, Satoshi; Masuda, Norikazu.
Afiliación
  • Ohtani S; Division of Breast Surgery, Hiroshima City Hiroshima Citizens Hospital, 7-33 Motomachi, Naka-ku, Hiroshima-shi, Hiroshima, 730-8518, Japan. sho_ohtani@hotmail.com.
  • Nakayama T; Osaka Medical Center for Cancer and Cardiovascular Diseases, 1-3-3 Nakamichi, Higashinari-ku, Osaka-shi, Osaka, Japan.
  • Yoshinami T; Osaka Medical Center for Cancer and Cardiovascular Diseases, 1-3-3 Nakamichi, Higashinari-ku, Osaka-shi, Osaka, Japan.
  • Watanabe KI; NHO Hokkaido Cancer Center, 3-54 4-jo 2-chome Kikusui Shiroishi-ku, Sapporo-shi, Hokkaido, Japan.
  • Hara F; Department of Breast Oncology, NHO Shikoku Cancer Center, 160 Kou, Minamiumemoto-machi, Matsuyama-shi, Ehime, Japan.
  • Sagara Y; Division of Breast Surgery, Hakuaikai Medical Corp. Sagara Hospital, 3-28 Matsubara-cho, Kagoshima-shi, Japan.
  • Kawaguchi H; Matsuyama Red Cross Hospital, 1 Bunkyo-cho, Matsuyama-shi, Ehime, Japan.
  • Higaki K; Higaki Breast Clinic, 8-23 Hondori, Naka-ku, Hiroshima-shi, Hiroshima, Japan.
  • Matsunami N; Osaka Rosai Hospital, 1179-3 Nagasonecho, Kita-ku,, Sakai-shi, Osaka, Japan.
  • Hasegawa Y; Department of Breast Surgery, Hirosaki Municipal Hospital, 3-8-1 Omachi, Hirosaki-shi, Aomori, Japan.
  • Takahashi M; NHO Hokkaido Cancer Center, 3-54 4-jo 2-chome Kikusui Shiroishi-ku, Sapporo-shi, Hokkaido, Japan.
  • Mizutani M; Department of Surgery, Breast Oncology, NHO Osaka National Hospital, Chu-ouku Hoenzaka 2-1-14, Osaka-shi, Osaka, Japan.
  • Morimoto T; Yao Municipal Hospital, 1-3-1 Ryuge-cho, Yao-shi, Osaka, Japan.
  • Sato M; NHO Hokkaido Cancer Center, 3-54 4-jo 2-chome Kikusui Shiroishi-ku, Sapporo-shi, Hokkaido, Japan.
  • Itoh M; Division of Breast Surgery, Hiroshima City Hiroshima Citizens Hospital, 7-33 Motomachi, Naka-ku, Hiroshima-shi, Hiroshima, 730-8518, Japan.
  • Morita S; Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, Japan.
  • Masuda N; Department of Surgery, Breast Oncology, NHO Osaka National Hospital, Chu-ouku Hoenzaka 2-1-14, Osaka-shi, Osaka, Japan.
Breast Cancer ; 25(4): 438-446, 2018 Jul.
Article en En | MEDLINE | ID: mdl-29435730
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Furanos / Cetonas / Antineoplásicos Tipo de estudio: Clinical_trials / Observational_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Furanos / Cetonas / Antineoplásicos Tipo de estudio: Clinical_trials / Observational_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Japón